natgillin/translations-raw huggingface dataset:
Extremities (fingers, toe, hand, foot)
okončine (prst na roki, prst na nogi, roka, stopalo)
Forearm
podlaket
Leg
noga
Pelvis
medenica
Spinal cord
hrbtenjača
Mid-low neck
srednji-spodnji del vratu
Chest (massive crushing)
prsni koš (močna zdrobitev)
Finger(s)
prst(-i) na roki
Toe(s)
prst(-i) na nogi
Hand
roka
Foot
stopalo
(Part of) Arm
roka (del roke)
Eye
oko
Both extremities
obe okončini
Piercing, puncturing
predrtje, prebod
Limited depth, only skin involved
omejena globina, prizadeta samo koža
Deeper than skin
globlje kot koža
Abdominal wall (no organ involvement)
trebušna stena (organi niso prizadeti)
Chest wall
stena prsnega koša
Deep injuries in organs (liver, kidney, bowel, etc.)
poškodbe notranjih organov (jetra, ledvica, črevo itn.)
Ingestion
zaužitje
Internal organ injury
poškodba notranjih organov
(Refer also to internal airway obstruction where the ingested object gets stuck high in the oesophagus.)
(nanaša se tudi na zaprtje notranjih dihalnih poti, ko se zaužiti predmet zatakne v požiralniku.)
Permanent damage to internal organ
trajna poškodba notranjih organov
Internal airway obstruction
zaprtje notranje dihalne poti
Oxygen flow to brain blocked without permanent consequences
oviran dotok kisika do možganov brez trajnih posledic
Oxygen flow to brain blocked with permanent consequences
oviran dotok kisika do možganov s trajnimi posledicami
Suffocation/Strangulation
zadušitev/zadavljenje
Fatal suffocation/strangulation
zadušitev/zadavljenje s smrtnim izidom
Submersion/Drowning
potopitev/utopitev
Fatal drowning
utopitev s smrtnim izidom
Burn/Scald (by heat, cold, or chemical substance)
opekline/oparine (s toploto, mrazom ali kemično snovjo)
1o, up to 100 % of body surface
1°, do 100 % telesne površine
2o, < 6 % of body surface
2°, < 6 % telesne površine
2o, 6-15 % of body surface
2°, 6–15 % telesne površine
2o, 16-35 % of body surface, or 3o, up to 35 % of body surface
2°, 16–35 % telesne površine, ali 3°, do 35 % telesne površine
Inhalation burn
opekline zaradi vdihavanja
or 3o, > 35 % of body surface
ali 3°, > 35 % telesne površine
Inhalation burn requiring respiratory assistance
opekline zaradi vdihavanja zahtevajo pomoč pri dihanju
(See also under burns as electric current can cause burns.)
(glej tudi pod opekline, ker lahko električni tok povzroči opekline.)
Local effects (temporary cramp or muscle paralysis)
lokalni učinki (začasni krč ali mišična paraliza)
Neurological disorders
nevrološke motnje
Triggered epileptic seizure
sprožen epileptični napad
Eye injury, foreign body in eye
poškodbe oči, tujek v očesu
Temporary pain in eye without need for treatment
začasna bolečina v očesu brez potrebe po zdravljenju
Temporary loss of sight
začasna izguba vida
Partial loss of sight
delna izguba vida
Permanent loss of sight (one eye)
trajna izguba vida (eno oko)
Permanent loss of sight (both eyes)
stalna izguba vida (obe očesi)
Hearing injury, foreign body in ear
poškodbe sluha, tujek v ušesu
Temporary pain in ear without need for treatment
začasna bolečina v ušesu brez potrebe po zdravljenju
Temporary impairment of hearing
začasno poslabšanje sluha
Partial loss of hearing
delna izguba sluha
Complete loss of hearing (one ear)
popolna izguba sluha (eno uho)
Complete loss of hearing (both ears)
popolna izguba sluha (obe ušesi)
Poisoning from substances (ingestion, inhalation, dermal)
zastrupitev s snovmi (zaužitje, vdihavanje, skozi kožo)
Diarrhoea, vomiting, local symptoms
driska, bruhanje, lokalni simptomi
Reversible damage to internal organs, e.g. liver, kidney, slight haemolytic anaemia
ozdravljiva poškodba notranjih organov, npr. jeter, ledvic, rahla hemolitična anemija
Irreversible damage to internal organs, e.g. oesophagus, stomach, liver, kidney, haemolytic anaemia, reversible damage to nerve system
trajna poškodba notranjih organov, npr. požiralnika, želodca, jeter, ledvic, hemolitična anemija, ozdravljiva poškodba živčnega sistema
Irreversible damage to nerve system
trajna poškodba živčnega sistema
Fatality
smrtni primer
Irritation, dermatitis, inflammation or corrosive effect of substances (inhalation, dermal)
draženje, dermatitis, vnetje ali jedek učinek snovi (vdihavanje, skozi kožo)
Local slight irritation
rahlo lokalno draženje
Reversible eye damage
ozdravljiva poškodba oči
Reversible systemic effects
ozdravljivi sistemski učinki
Inflammatory effects
vnetni učinki
Lungs, respiratory insufficiency, chemical pneumonia
pljuča, respiracijska insuficienca, kemična pljučnica
Irreversible systemic effects
trajni sistemski učinki
Corrosive effects
jedek učinek
Lungs, requiring respiratory assistance
pljuča, potrebna pomoč pri dihanju
Asphyxia
asfiksija
Allergic reaction or sensitisation
alergijske reakcije ali preobčutljivost
Mild or local allergic reaction
blaga ali lokalna alergijska reakcija
Allergic reaction, widespread allergic contact dermatitis
alergijska reakcija, razširjeni alergijski kontaktni dermatitis
Strong sensitisation, provoking allergies to multiple substances
močna preobčutljivost, ki povzroča alergije na več snovi
Anaphylactic reaction, shock
anafilaktična reakcija, šok
Long-term damage from contact with substances or from exposure to radiation
dolgotrajna poškodba zaradi stika s snovmi ali izpostavljenosti sevanju
Cancer (leukaemia)
rak (levkemija)
Effects on reproduction
vpliv na razmnoževanje
Effects on offspring
vpliv na potomce
Reversible damage
mikrobiološka okužba
Irreversible effects
ozdravljiva poškodba
Infection requiring prolonged hospitalisation, antibiotics-resistant organisms
trajni učinki okužba zahteva daljšo hospitalizacijo, organizmi, odporni na antibiotike
Risk level from the combination of the severity of injury and probability
Stopnja tveganja iz kombinacije resnosti poškodbe in verjetnosti
Probability of damage during the foreseeable lifetime of the product
Verjetnost poškodbe med predvideno življenjsko dobo proizvoda
High
Velika
Low
Majhna
S — Serious Risk
R – Resno tveganje
H — High risk
V – Veliko tveganje
M — Medium risk
S – Srednje tveganje
L — Low risk
N – Majhno tveganje
Hazard: Source of danger involving the chance of being injured or harmed.
Nevarnost: Vir nevarnosti, ki vključuje možnost poškodbe ali škode.
A means of quantifying the hazard in a risk assessment is the severity of the possible injury or harm.
Sredstvo za količinsko opredelitev nevarnosti v oceni tveganja je resnost možne poškodbe ali škode.
Product hazard: Hazard created by the properties of a product.
Nevarnost proizvoda: Nevarnost, ki izvira iz lastnosti proizvoda.
Risk: Balanced combination of a hazard and the probability that damage will occur.
Tveganje: Uravnotežena kombinacija nevarnosti in verjetnosti, da se bo poškodba zgodila.
Risk assessment: Procedure for identifying and assessing hazards, consisting of three steps:
Ocena tveganja: Postopek za ugotavljanje in ocenjevanje nevarnosti, sestavljen iz treh korakov:
identification of the seriousness of a hazard;
ugotovitev resnosti nevarnosti,
determination of the probability that a consumer will be injured by that hazard;
določitev verjetnosti, da bo potrošnik utrpel poškodbo zaradi te nevarnosti,
combination of the hazard with the probability.
kombinacija nevarnosti z verjetnostjo.
Risk level: Degree of risk, which may be ‘serious’, ‘high’, ‘medium’ and ‘low’.
Stopnja tveganja: Stopnja tveganja, ki je lahko „resno“, „visoko“, „srednje“ ali „nizko“.
When the (highest) level of risk has been identified, the risk assessment is complete.
Kadar je ugotovljena (najvišja) stopnja tveganja, je ocena tveganja dokončana.
Risk management: Follow-up action, which is separate from risk assessment and aims to reduce or eliminate a risk.
Obvladovanje tveganja: Nadaljnji ukrep, ki je ločen od ocene tveganja, njegov cilj pa je znižati ali odpraviti tveganje.
In the Guidelines, the term ‘Commission’ generally refers to the RAPEX Team established in the Commission department responsible for the GPSD and to the relevant Commission services, where appropriate.
V smernicah se izraz „Komisija“ na splošno nanaša na Skupino RAPEX, ki je bila ustanovljena v oddelku Komisije, odgovornem za GPSD, in na ustrezne službe Komisije, kadar je to primerno.
In the context of this document, the term ‘Member States’ means all countries which belong to the European Union and also those countries which are parties to the European Economic Area (EEA) Agreement.
V tem dokumentu izraz „države članice“ pomeni vse države, ki pripadajo Evropski uniji, in tudi tiste države, ki so pogodbenice Sporazuma EGP.
For more information about deadlines, see Chapter 3.10 of the Guidelines.
Za več informacij o rokih glej poglavje 3.10 smernic.
For more information about the RAPEX Contact Points and their obligations, see Chapter 5.1 of the Guidelines.
Za več informacij o kontaktnih točkah RAPEX in njihovih obveznostih glej poglavje 5.1 smernic.
For more information on follow-up actions, see Chapter 3.7.
Za več informacij o nadaljnjih ukrepih glej poglavje 3.7.
For more information on notifications on safety aspects subject to discussions at EU level, see Chapters 3.5.2 and 3.8.1.
Za več informacij o obvestilih v zvezi z varnostnimi vidiki, ki so predmet razprav na ravni EU, glej poglavji 3.5.2 in 3.8.1.
For more information on notifications on safety aspects subject to discussions at EU level, see Chapters 3.1.2.d and 3.8.1.
Za več informacij o obvestilih v zvezi z varnostnimi vidiki, ki so predmet razprav na ravni EU, glej poglavji 3.1.2 in 3.8.1.
For more information on the RAPEX notification criteria, see Chapter 2.
Za več informacij o merilih za obveščanje RAPEX glej poglavje 2.
For more information on notifications sent through the RAPEX application before measures are taken, see Chapter 3.1.2 b.
Za več informacij o obvestilih, poslanih prek aplikacije RAPEX pred sprejemom ukrepov, glej poglavje 3.1.2(b).
For more information on notifications on safety aspects subject to discussions at EU level, see Chapters 3.1.2.d and 3.5.2.
Za več informacij o obvestilih v zvezi z varnostnimi vidiki, ki so predmet razprav na ravni EU, glej poglavji 3.1.2 in 3.5.2.
All deadlines mentioned in the Guidelines are expressed in calendar days.
Vsi roki v smernicah so izraženi v koledarskih dnevih.
Benis HG (1990): A Product Risk Assessment Nomograph, report prepared for the New Zealand Ministry of Consumer Affairs, dated February 1990.
Benis H (1990): A Product Risk Assessment Nomograph, report prepared for the New Zealand Ministry of Consumer Affairs, februar 1990.
Cited in: European Commission (2005) Establishing a Comparative Inventory of Approaches and Methods Used by Enforcement Authorities for the Assessment of the Safety of Consumer Products Covered by Directive 2001/95/EC on General Product Safety and Identification of Best Practices.
Citirano v: Evropska komisija (2005) Vzpostavitev primerjalne evidence pristopov in načinov, ki jih uporabljajo izvršilni organi za oceno varnosti potrošniških proizvodov v skladu z Direktivo 2001/95/ES o splošni varnosti proizvodov in določitvi najboljših praks.
Report prepared by Risk & Policy Analysts (RPA), Loddon, Norfolk, UK.
Poročilo pripravil Risk & Policy Analysts (RPA), London, Norfolk, Združeno kraljestvo.
Method used by the Belgian authorities.
Metodo uporabljajo belgijski organi.
Commission Decision 2004/418/EC of 29 April 2004 laying down guidelines for the management of the Community Rapid Information System (RAPEX) and for notifications presented in accordance with Article 11 of Directive 2001/95/EC (OJ L 151, 30.4.2004, p. 83).
Odločba Komisije 2004/418/ES z dne 29. aprila 2004 o določitvi smernic za upravljanje hitrega informacijskega sistema Skupnosti (RAPEX) in za uradna obvestila, predstavljena v skladu s členom 11 Direktive 2001/95/ES (UL L 151, 30.4.2004, str. 83).
Directive 2001/95/EC of the European Parliament and of the Council of 3 December 2001 on general product safety (OJ L 11, 15.1.2002, p. 4).
Direktiva 2001/95/ES Evropskega parlamenta in Sveta z dne 3. decembra 2001 o splošni varnosti proizvodov (UL L 11, 15.1.2002, str. 4).
China Lake, CA: NWC Technical Publication 5865, Naval Weapons Center, California, June 1976.
China Lake, CA: NWC Technical Publication 5865, Naval Weapons Center, Kalifornija, junij 1976.
uncertainty always has to be taken into account when comparing a test result with a limit.
Opomba: Negotovost je treba upoštevati vedno, kadar se rezultati preskusov primerjajo z mejnimi vrednostmi.
See, for example:the ‘Report on the relationship between analytical results, measurement uncertainty, recovery factors and the provisions of EU food and feed legislation …’ http://ec.europa.eu/food/food/chemicalsafety/contaminants/report-sampling_analysis_2004_en.pdf the Summary report on the ‘Preparation of a working document in support of the uniform interpretation of legislative standards and the laboratory quality standards prescribed under Directive 93/99/EEC’. http://ec.europa.eu/food/fs/scoop/9.1_sr_en.pdf
Za primer glej:„Poročilo o razmerju med analitičnimi rezultati, nezanesljivostjo meritev, faktorji izplena in določbami zakonodaje EU o krmi in živilih“ http://ec.europa.eu/food/food/chemicalsafety/contaminants/report-sampling_analysis_2004_en.pdf; Zbirno poročilo „Priprava delovnega dokumenta v podporo enotni razlagi zakonodajnih standardov in laboratorijskih standardov, predpisanih v skladu z Direktivo 93/99/EGS“. http://ec.europa.eu/food/fs/scoop/9.1_sr_en.pdf.
Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).
Uredba (ES) št. 1907/2006 Evropskega parlamenta in Sveta z dne 18. decembra 2006 o registraciji, evalvaciji, avtorizaciji in omejevanju kemikalij (REACH), o ustanovitvi Evropske agencije za kemikalije ter spremembi Direktive 1999/45/ES ter razveljavitvi Uredbe Sveta (EGS) št. 793/93 in Uredbe Komisije (ES) št. 1488/94 ter Direktive Sveta 76/769/EGS in direktiv Komisije 91/155/EGS, 93/67/EGS, 93/105/ES in 2000/21/ES. UL L 396, 30.12.2006, str. 1.
Standard EN 71-1:2005, section 8.2 +A6:2008.
Standard EN 71-1:2005, oddelek 8.2 + A6:2008.
Article 7a(1)(d) of Council Directive 76/768/EEC (OJ L 262, 27.9.1976, p. 169).
Člen 7a(1)(d) Direktive 76/768/EGS o kozmetičnih proizvodih. UL L 262, 27.9.1976, str. 169.
REACH Regulation and guidance documents on REACH, see http://echa.europa.eu/European Chemicals Agency (2008).
Uredba REACH in dokumenti z navodili za REACH, glej http://echa.europa.eu/.Evropska agencija za kemikalije (2008).
The Guidance on Information Requirements and Chemical Safety Assessment: http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm
Smernice o zahtevah po informacijah in oceni kemijske varnosti. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm.
Scientific Committee on Consumer Products (SCCP), The SCCP’s Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation, 6th revision, 19.12.2006: http://ec.europa.eu/enterprise/cosmetics/html/testing_guidance.htm
Znanstveni odbor za proizvode za potrošnike (SCCP), Smernice SCCP za preskušanje kozmetičnih sestavin in njihovo oceno varnosti, 6. sprememba, 19.12.2006. http://ec.europa.eu/enterprise/cosmetics/html/testing_guidance.htm.
This is taken from the definition of ‘safe product’ in Article 2(b) of Directive 2001/95/EC.
Vzeto iz opredelitve „varnega proizvoda“ v členu 2(b) Direktive 2001/95/ES.
The ‘Guidelines for the management of the Community Rapid Information System “RAPEX” established under Article 12 and of the notification procedure established under Article 11 of Directive 2001/95/EC (the General Product Safety Directive)’ (the ‘Guidelines’) are adopted by the Commission [1] pursuant to Article 11(1) and Annex II, point 8, of Directive 2001/95/EC [2] of the European Parliament and of the Council of 3 December 2001 on general product safety (the ‘GPSD’), which is assisted by an advisory committee composed of the representatives of Member States and established under Article 15(3) of the GPSD. Point 8 of Annex II to the GPSD reads as follows: ‘The Commission shall prepare and regularly update, in accordance with the procedure laid down in Article 15(3), guidelines concerning the management of RAPEX by the Commission and Member States’. Furthermore, Article 11(1) of the GPSD states that the guidelines drafted for the purpose of the RAPEX notification procedure should also regulate various aspects of the notification procedure established under Article 11 of the GPSD.
Komisija sprejme „smernice za upravljanje hitrega informacijskega sistema Skupnosti (RAPEX) iz člena 12 in postopka obveščanja iz člena 11 Direktive 2001/95/ES (Direktiva o splošni varnosti proizvodov)“ (v nadaljnjem besedilu: smernice) [1] v skladu s členom 11 in točko 8 Priloge II k Direktivi 2001/95/ES Evropskega parlamenta in Sveta z dne 3. decembra 2001 o splošni varnosti proizvodov [2] (v nadaljnjem besedilu: GPSD) ob pomoči posvetovalnega odbora, ki ga sestavljajo predstavniki držav članic in je bil ustanovljen s členom 15(3) GPSD.Točka 8 Priloge II k GPSD se glasi: „Komisija po postopku iz člena 15(3) pripravi in redno posodablja smernice o tem, kako naj Komisija in države članice upravljajo RAPEX.“ Poleg tega člen 11(1) GPSD navaja, da morajo smernice, pripravljene za namen postopka obveščanja RAPEX, urejati tudi različne vidike postopka obveščanja iz člena 11 GPSD.
However, the structure and content of the Guidelines allow them to be adapted, if and as appropriate, to include provisions relating to the notification procedure established under Article 22 of Regulation (EC) No 765/2008 of the European Parliament and of the Council of 9 July 2008 setting out the requirements for accreditation and market surveillance relating to the marketing of products and repealing Regulation (EEC) No 339/93 [3].Member States [4], applicant countries, as well as third countries and international organisations which are granted access to RAPEX (on the conditions defined in Article 12(4) of the GPSD), participate in the system according to the rules provided for in the GPSD and the Guidelines.1.2. Objectives
Vendar struktura in vsebina smernic omogočata njihovo prilagajanje, če in kot je to primerno, z vključevanjem določb v zvezi s postopkom obveščanja v skladu s členom 22 Uredbe (ES) št. 765/2008 Evropskega Parlamenta in Sveta z dne 9. julija 2008 o določitvi zahtev za akreditacijo in nadzor trga v zvezi s trženjem proizvodov ter razveljavitvi Uredbe (EGS) št. 339/93 [3].Države članice [4], države prosilke, pa tudi tretje države in mednarodne organizacije, ki imajo omogočen dostop do RAPEX (pod pogoji iz člena 12(4) GPSD), sodelujejo v sistemu v skladu s pravili iz GPSD in smernic.1.2 Cilji
food and feed covered by Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety [6];medicinal products covered by Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use [7], and Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products [8];medical devices covered by Council Directive 93/42/EEC of 14 June 1993 concerning medical devices [9];in vitro diagnostic medical devices covered by Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices [10];active implantable medical devices covered by Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices [11].2.2. Measures
hrana in krma, zajeti v Uredbi (ES) št. 178/2002 Evropskega parlamenta in Sveta z dne 28. januarja 2002 o določitvi splošnih načel in zahtevah živilske zakonodaje, ustanovitvi Evropske agencije za varnost hrane in postopkih, ki zadevajo varnost hrane [6],zdravila, zajeta v Direktivi 2001/83/ES Evropskega parlamenta in Sveta z dne 6. novembra 2001 o zakoniku Skupnosti o zdravilih za uporabo v humani medicini [7] in Direktivi 2001/82/ES Evropskega parlamenta in Sveta z dne 6. novembra 2001 o zakoniku Skupnosti o zdravilih za uporabo v veterinarski medicini [8],zdravila, zajeta v Direktivi Sveta 93/42/EGS z dne 14. junija 1993 o medicinskih pripomočkih [9],in vitro diagnostični medicinski pripomočki, zajeti v Direktivi 98/79/ES Evropskega parlamenta in Sveta z dne 27. oktobra 1998 o in vitro diagnostičnih medicinskih pripomočkih [10],aktivni medicinski pripomočki za vsaditev, zajeti v Direktivi Sveta 90/385/EGS z dne 20. junija 1990 o približevanju zakonodaje držav članic o aktivnih medicinskih pripomočkih za vsaditev [11].2.2 Ukrepi
All such national measures that apply to only generally defined categories of products, such as all products in general or all products serving the same purpose – and not to (categories of) products specifically identified by their brand, specific look, producer, trader, model name or number, etc. – are notified to the Commission under Directive 98/34/EC of the European Parliament and of the Council of 22 June 1998 laying down a procedure for the provision of information in the field of technical standards and regulations and of rules on Information Society services [12].2.2.5. Timing of the notification
O vseh nacionalnih ukrepih, ki veljajo samo za splošno opredeljene kategorije proizvodov, kot so vsi proizvodi na splošno, ali vsi proizvodi, ki se uporabljajo za isti namen, ne pa za proizvode (kategorije proizvodov), ki so posebej opredeljeni z blagovno znamko, značilnim videzom, proizvajalcem, trgovcem, imenom ali številko modela itn., je treba obvestiti Komisijo v skladu z Direktivo 98/34/ES Evropskega parlamenta in Sveta z dne 22. junija 1998 Direktiva Evropskega parlamenta in Sveta o določitvi postopka za zbiranje informacij na področju tehničnih standardov in tehničnih predpisov o storitvah informacijske družbe [12].2.2.5 Časovni razpored obveščanja
The hammer head breaks when the user tries to knock a nail into a wall because the material of the hammer head is too weak.
Glava kladiva poči, ko uporabnik zabija žebelj v steno, ker je material, iz katerega je izdelana glava kladiva, prekrhek.
The probability of this happening is put at 1/10, since the area of upper body exposed to the pieces flying off is considered to be 1/10 of the half-sphere in front of the wall.
Verjetnost tega dogodka je 1/10, saj je območje izpostavljenosti zgornjega dela telesa koščkom, ki odletavajo, predvidoma 1/10 polkrogle pred zidom.
Of course, if the user were standing very close to the wall, his body would take a larger share of the half-sphere, and the probability would be higher.
Če bi uporabnik stal zelo blizu stene, bi njegovo telo zavzelo večji delež polkrogle in verjetnost bi bila večja.
The piece hits the user on the head.
Delec udari uporabnika v glavo.
The head is estimated to be about 1/3 of the upper body, and the probability is therefore 1/3.
Glava naj bi predstavljala 1/3 zgornjega dela telesa in verjetnost je zato 1/3.
Once the overall probability has been calculated for an injury scenario, it should be checked for plausibility.
Ko je izračunana celotna verjetnost scenarija poškodbe, je treba preveriti njeno verodostojnost.
As experience is gained with these guidelines estimating probability should become easier, and an increasing number of examples will become available to facilitate this task.
Z izkušnjami, pridobljenimi na podlagi teh smernic, je ocenjevanje verjetnosti lažje, na voljo pa bo vedno večje število primerov, ki bodo olajšali to nalogo.
Assigning probabilities to different injury scenarios for the same product may lead to the following:
Rezultati določanja verjetnosti za različne scenarije poškodb za isti proizvod so lahko naslednji: